At a glance
- Appearance specifications should cover both shell and fill under defined inspection conditions.
- Natural-origin colors still require applicable identity, purity, and use review.
- Color and transparency do not establish potency or effectiveness.
Specify the assembled capsule appearance
A softgel's visible appearance reflects both the shell and the fill. Describe whether the intended capsule is transparent, translucent, or opaque, and define the preferred hue using physical reference samples. A photograph can guide a first discussion, but lighting, screen settings, and reflections make it an unreliable final color acceptance standard.
For a clear-shell concept, review the actual fill because its color will remain visible. If the brand wants multiple products to share one appearance, compare those formulas side by side before committing to a common shell. A darker ingredient blend may require a different visual approach even when the capsule shape and shell recipe stay the same.
Translate preferences into repeatable checks
Replace requests such as premium amber or perfectly clear with an agreed comparison procedure. Specify the lighting, background, sample age, and reference material used for inspection. If instrumental color measurement is proposed, have qualified staff select the method and tolerance based on the actual product rather than borrowing a value from an unrelated capsule.
Record acceptable variation, surface appearance, visible particles, bubbles, and other attributes relevant to the chosen fill. A suspended ingredient may call for a different appearance specification from a dissolved ingredient. The aim is a consistent review of the intended formulation, not a blanket rejection of any feature that differs from a generic product photograph.
Review every color ingredient for the intended US use
FDA explains that color additives must comply with their individual listing regulations, including applicable specifications, uses, and restrictions. Ask for the exact color ingredient identity and documentation supporting the proposed supplement use. A color offered for cosmetics or another food application should not be accepted for a softgel solely because its shade matches the brand palette.
FDA also states that colors exempt from batch certification still must meet applicable identity and purity specifications. A natural-origin description therefore does not replace regulatory and quality review. Have qualified reviewers check current requirements for the actual ingredient and proposed market; avoid choosing a color from an outdated list or making broad claims about which colors are universally permitted.
Keep appearance claims separate from efficacy
Clear, dark, or brightly colored capsules do not independently establish ingredient potency, purity, absorption, or product effectiveness. Keep marketing descriptions tied to attributes the brand can verify. If a color change appears during evaluation, record it and investigate with the relevant analytical information instead of claiming that the ingredient has necessarily lost activity.
Consider two samples with the same declared ingredient amount but different carrier colors. A visual comparison can identify the difference, while a suitable assay addresses the ingredient content. Keep those decisions separate. Similarly, do not describe an opaque shell as proven light protection without evaluating the assembled capsule and package against the intended stability requirement.
Approve a reference set and control later changes
The appearance approval should identify the formula revision, shell and fill materials, inspection procedure, approved reference samples, and agreed tolerances. Retain more than one representative unit when practical. Document how references will be stored and replaced, because an aging reference sample may no longer represent the original approved appearance.
A change in oil supplier, shell color ingredient, or capsule dimensions should trigger a review of the affected appearance and label information. Evaluate the revised sample in the actual package as well as outside it. This gives the purchasing team a concrete acceptance standard while keeping the brand's visual direction connected to the composition that will be produced.
Common questions
Can we approve the final softgel color from a digital image?
A digital image can guide development, but a physical reference and defined inspection procedure are better suited to final appearance approval because displays and lighting vary.
Does a darker softgel mean its ingredient is stronger?
No. Color may come from the fill, shell, or added ingredients. Ingredient identity and quantity need appropriate documentation and testing rather than visual inference.
Sources & further reading
- FDA: Understanding How Color Additives Are Regulated
- FDA: Identity and Purity Requirements for Certification-Exempt Color Additives
These sources support the general technical context. They do not verify the credentials or capacity of a specific factory. This guide is for manufacturing planning; it does not provide medical advice or product efficacy claims.